2024P Supportive Measures to Control Myelosuppression and Costs for Patients with SCLC with Lurbinectedin, CAV or Topotecan with or Without Trilaciclib: A Review on the Basis of Clinical Trials
ANNALS OF ONCOLOGY（2023）
Key words
Small-Cell Lung Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined